DL-2-amino-3-phosphonopropionic acid protects primary neurons from oxygen-glucose deprivation induced injury

Di Cui; Jun Xu; Quanyi Xu; Guokun Zuo

doi:10.17305/bjbms.2016.1553

Authors

Di Cui Department of Robot and Neuro-Rehabilitation, Ningbo Institute of Industrial Technology, Chinese Academy of Sciences, Ningbo, China; Department of Computer Science, Ningbo University of Technology, Ningbo, China
Jun Xu Department of Neurology, Yinzhou Second Hospital of Ningbo, Ningbo, China
Quanyi Xu Department of Pharmacy, Zhejiang Pharmaceutical College, Ningbo, China
Guokun Zuo Department of Robot and Neuro-Rehabilitation, Ningbo Institute of Industrial Technology, Chinese Academy of Sciences, Ningbo, China

DOI:

https://doi.org/10.17305/bjbms.2016.1553

Keywords:

DL-2-amino-3-phosphonopropionic acid, cerebral infarction, oxygen-glucose deprivation, neuron viability, apoptosis

Abstract

Cerebral infarction is a type of ischemic stroke and is one of the main causes of irreversible brain damage. Although multiple neuroprotective agents have been investigated recently, the potential of DL-2-amino-3-phosphonopropionic acid (DL-AP3) in treating oxygen-glucose deprivation (OGD)-induced neuronal injury, has not been clarified yet. This study was aimed to explore the role of DL-AP3 in primary neuronal cell cultures. Primary neurons were divided into four groups: (1) a control group that was not treated; (2) DL-AP3 group treated with 10 μM of DL-AP3; (3) OGD group, in which neurons were cultured under OGD conditions; and (4) OGD + DL-AP3 group, in which OGD model was first established and then the cells were treated with 10 μM of DL-AP3. Neuronal viability and apoptosis were measured using Cell Counting Kit-8 and flow cytometry. Expressions of phospho-Akt1 (p-Akt1) and cytochrome c were detected using Western blot. The results showed that DL-AP3 did not affect neuronal viability and apoptosis in DL-AP3 group, nor it changed p-Akt1 and cytochrome c expression (p > 0.05). In OGD + DL-AP3 group, DL-AP3 significantly attenuated the inhibitory effects of OGD on neuronal viability (p < 0.001), and reduced OGD induced apoptosis (p < 0.01). Additionally, the down-regulation of p-Akt1 and up-regulation of cytochrome c, induced by OGD, were recovered to some extent after DL-AP3 treatment (p < 0.05 or p < 0.001). Overall, DL-AP3 could protect primary neurons from OGD-induced injury by affecting the viability and apoptosis of neurons, and by regulating the expressions of p-Akt1 and cytochrome c.

Downloads

Download data is not yet available.

Author Biographies

Di Cui, Department of Robot and Neuro-Rehabilitation, Ningbo Institute of Industrial Technology, Chinese Academy of Sciences, Ningbo, China; Department of Computer Science, Ningbo University of Technology, Ningbo, China

Department of Robot and Neuro-Rehabilitation;
Department of Computer Science
Jun Xu, Department of Neurology, Yinzhou Second Hospital of Ningbo, Ningbo, China

Department of Neurology
Quanyi Xu, Department of Pharmacy, Zhejiang Pharmaceutical College, Ningbo, China

Department of Pharmacy
Guokun Zuo, Department of Robot and Neuro-Rehabilitation, Ningbo Institute of Industrial Technology, Chinese Academy of Sciences, Ningbo, China

Department of Robot and Neuro-Rehabilitation

References

Liu JJ, Pan SY. Protective effects of estrogen combined with sevoflurane in an experimental model of cerebral infarction and focal cerebral ischemia-reperfusion injury. Eur Rev Med Pharmacol Sci 2016;20(9):1839-44.

Hankey GJ. Potential new risk factors for ischemic stroke: what is their potential? Stroke 2006;37(8):2181-8. http://dx.doi.org/10.1161/01.STR.0000229883.72010.e4.

Liu N, Zhang Y, Fan L, Yuan M, Du H, Cheng R, et al. Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats. J Transl Med 2011;9:105.

http://dx.doi.org/10.1186/1479-5876-9-105.

Wang S, Zhou J, Kang W, Dong Z, Wang H. Tocilizumab inhibits neuronal cell apoptosis and activates STAT3 in cerebral infarction rat model. Bosn J Basic Med Sci 2016;16(2):145-50. http://dx.doi.org/10.17305/bjbms.2016.853.

Onteddu SR, Goddeau RP Jr, Minaeian A, Henninger N. Clinical impact of leukoaraiosis burden and chronological age on neurological deficit recovery and 90-day outcome after minor ischemic stroke. J Neurol Sci 2015;359(1-2):418-23. http://dx.doi.org/10.1016/j.jns.2015.10.005.

Slomka M, Kuszczyk M, Lazarewicz JW, Makarewicz D. NMDA receptor antagonists MK-801 and memantine induce tolerance to oxygen and glucose deprivation in primary cultures of rat cerebellar granule cells. Acta Neurobiol Exp (Wars) 2014;74(4):396-404.

Kanthan R, Shuaib A, Griebel R, Miyashita H. Intracerebral human microdialysis. In vivo study of an acute focal ischemic model of the human brain. Stroke 1995;26(5):870-3. http://dx.doi.org/10.1161/01.STR.26.5.870.

Fisher M. Characterizing the target of acute stroke therapy. Stroke 1997;28(4):866-72. http://dx.doi.org/10.1161/01.STR.28.4.866.

Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262(5134):689-95. http://dx.doi.org/10.1126/science.7901908.

Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999;283(5398):70-4. http://dx.doi.org/10.1126/science.283.5398.70.

Yun BR, Yang HJ, Weon JB, Lee J, Eom MR, Ma CJ. Neuroprotective properties of compounds extracted from Dianthus superbus L. against glutamate-induced cell death in HT22 cells. Pharmacogn Mag 2016;12(46):109-13.

http://dx.doi.org/10.4103/0973-1296.177905.

Kuszczyk M, Slomka M, Antkiewicz-Michaluk L, Salinska E, Lazarewicz JW. 1-Methyl-1,2,3,4-tetrahydroisoquinoline and established uncompetitive NMDA receptor antagonists induce tolerance to excitotoxicity. Pharmacol Rep 2010;62(6):1041-50. http://dx.doi.org/10.1016/S1734-1140(10)70366-2.

Ke T, Li R, Chen W. Inhibition of the NMDA receptor protects the rat sciatic nerve against ischemia/reperfusion injury. Exp Ther Med 2016;11(5):1563-72.

http://dx.doi.org/10.3892/etm.2016.3148.

Adachi N, Numakawa T, Kumamaru E, Itami C, Chiba S, Iijima Y, et al. Phencyclidine-induced decrease of synaptic connectivity via inhibition of BDNF secretion in cultured cortical neurons. Cereb Cortex 2013;23(4):847-58. http://dx.doi.org/10.1093/cercor/bhs074.

Xu SY, Wu YM, Ji Z, Gao XY, Pan SY. A modified technique for culturing primary fetal rat cortical neurons. J Biomed Biotechnol 2012;2012:803930. http://dx.doi.org/10.1155/2012/803930.

Gao XY, Huang JO, Hu YF, Gu Y, Zhu SZ, Huang KB, et al. Combination of mild hypothermia with neuroprotectants has greater neuroprotective effects during oxygen-glucose deprivation and reoxygenation-mediated neuronal injury. Sci Rep 2014;4:7091. http://dx.doi.org/10.1038/srep07091.

Wang Z, Yang P, Qi Y. Role of microRNA-134 in the neuroprotective effects of propofol against oxygen-glucose deprivation and related mechanisms. Int J Clin Exp Med 2015;8(11):20617-23.

Vieira M, Fernandes J, Carreto L, Anuncibay-Soto B, Santos M, Han J, et al. Ischemic insults induce necroptotic cell death in hippocampal neurons through the up-regulation of endogenous RIP3. Neurobiol Dis 2014;68:26-36.

http://dx.doi.org/10.1016/j.nbd.2014.04.002.

Sheng R, Liu XQ, Zhang LS, Gao B, Han R, Wu YQ, et al. Autophagy regulates endoplasmic reticulum stress in ischemic preconditioning. Autophagy 2012;8(3):310-25. http://dx.doi.org/10.4161/auto.18673.

Pan XW, Zhao XH. In vitro proliferation and anti-apoptosis of the papain-generated casein and soy protein hydrolysates towards osteoblastic cells (hFOB1.19). Int J Mol Sci 2015;16(6):13908-20. http://dx.doi.org/10.3390/ijms160613908.

Zhang N, Su Y, Xu L. Targeting PKCepsilon by miR-143 regulates cell apoptosis in lung cancer. FEBS Lett 2013;587(22):3661-7. http://dx.doi.org/10.1016/j.febslet.2013.09.018.

Nam K, Oh S, Lee KM, Yoo SA, Shin I. CD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cells. Cell Signal 2015;27(9):1882-94. http://dx.doi.org/10.1016/j.cellsig.2015.05.002.

Trape AP, Liu S, Cortes AC, Ueno NT, Gonzalez-Angulo AM. Effects of CDK4/6 inhibition in hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer cells with acquired resistance to paclitaxel. J Cancer 2016;7(8):947-56. http://dx.doi.org/10.7150/jca.14441.

Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology 2008;55(3):310-8. http://dx.doi.org/10.1016/j.neuropharm.2008.01.005.

Aboutaleb N, Shamsaei N, Rajabi H, Khaksari M, Erfani S, Nikbakht F, et al. Protection of hippocampal CA1 neurons against ischemia/reperfusion injury by exercise preconditioning via modulation of Bax/Bcl-2 ratio and prevention of caspase-3 activation. Basic Clin Neurosci 2016;7(1):21-9.

Chalmers-Redman RM, Fraser AD, Ju WY, Wadia J, Tatton NA, Tatton WG. Mechanisms of nerve cell death: apoptosis or necrosis after cerebral ischaemia. Int Rev Neurobiol 1997;40:1-25. http://dx.doi.org/10.1016/S0074-7742(08)60713-8.

Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995;15(4):961-73.

http://dx.doi.org/10.1016/0896-6273(95)90186-8.

Bai X, Yan Y, Canfield S, Muravyeva MY, Kikuchi C, Zaja I, et al. Ketamine enhances human neural stem cell proliferation and induces neuronal apoptosis via reactive oxygen species-mediated mitochondrial pathway. Anesth Analg 2013;116(4):869-80. http://dx.doi.org/10.1213/ANE.0b013e3182860fc9.

Zhang Q, Shao Y, Zhao C, Cai J, Sun S. N-methyl-D-aspartate receptor antagonist MK-801 prevents apoptosis in rats that have undergone fetal spinal cord transplantation following spinal hemisection. Exp Ther Med 2014;8(6):1731-6.

http://dx.doi.org/10.3892/etm.2014.2029.

Migita H, Kominami K, Higashida M, Maruyama R, Tuchida N, McDonald F, et al. Activation of adenosine A1 receptor-induced neural stem cell proliferation via MEK/ERK and Akt signaling pathways. J Neurosci Res 2008;86(13):2820-8.

http://dx.doi.org/10.1002/jnr.21742.

Le Belle JE, Orozco NM, Paucar AA, Saxe JP, Mottahedeh J, Pyle AD, et al. Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell stem cell 2011;8(1):59-71. http://dx.doi.org/10.1016/j.stem.2010.11.028.

Groszer M, Erickson R, Scripture-Adams DD, Dougherty JD, Le Belle J, Zack JA, et al. PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry. Proc Natl Acad Sci U S A 2006;103(1):111-6.

http://dx.doi.org/10.1073/pnas.0509939103.

Jung SR, Kuok IT, Couron D, Rizzo N, Margineantu DH, Hockenbery DM, et al. Reduced cytochrome C is an essential regulator of sustained insulin secretion by pancreatic islets. J Biol Chem 2011;286(20):17422-34.

http://dx.doi.org/10.1074/jbc.M110.202820.